JP
DXCM icon

John Paulson’s DexCom DXCM Stock Holding History

John Paulson’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-733,600
Closed -$13.4M – 63
2017
Q2 		$13.4M Sell
733,600
-229,200
-24% -$4.23M 0.18% 53
2017
Q1 		$20.4M Sell
962,800
-210,000
-18% -$4.1M 0.27% 43
2016
Q4 		$17.5M Buy
1,172,800
+998,800
+574% +$17.7M 0.22% 52
2016
Q3 		$3.81M Sell
174,000
-320,000
-65% -$7.12M 0.04% 75
2016
Q2 		$9.8M Buy
494,000
+328,800
+199% +$5.6M 0.1% 58
2016
Q1 		$2.81M Buy
+165,200
New +$2.76M 0.02% 76

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

John Paulson's DXCM Position: Q3 2017 in Review

John Paulson sold out of DexCom (DXCM) in Q3 2017, closing a stake of 733,600 shares — an estimated $13.4M sold.

John Paulson first reported a position in DXCM in Q1 2016 and held it in 6 quarters. The position peaked at $20.4M in Q1 2017. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

  • John Paulson reported no remaining DexCom position as of Q3 2017 after selling out during the quarter.
  • John Paulson sold 733,600 DexCom shares in Q3 2017, an estimated $13.4M.
  • John Paulson first reported a position in DexCom in Q1 2016 and held it in 6 quarters.
  • John Paulson's DexCom position peaked at $20.4M in Q1 2017.
  • 275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.